MantiCore Pharmaceuticals Inc., Salt Lake City, Utah Business: Cancer Appointed: Bradley Lorimier as chairman, retired SVP of business development and a director of Human Genome Sciences Inc. WIR Staff cancer...

Inflabloc completed its stock merger with cancer company MantiCore. Financial terms were not disclosed. The combined company will have MantiCore's preclinical cobalamin bioconjugate cancer compounds and Inflabloc's dehydroepiandrosterone (DHEA) combination product, which is in Phase...

MantiCore Pharmaceuticals Inc. Salt Lake City, Utah Technology: Bioconjugate compounds for delivery of prodrugs Disease focus: Cancer Clinical status: Preclinical Founded: 1996 by Charles Grissom, Frederick West and Harry Hogenkamp Corporate partners: None University collaborators:...

MantiCore Pharmaceuticals Inc. takes its name from a mythical beast that has the head of a man, the body of a lion, and the tail of a scorpion. "It's an appropriate metaphor," said vice president...